ZA
FLXN

Zazove Associates’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Zazove Associates’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2.25M Buy
368,456
+78,466
+27% +$489K 0.2% 70
2021
Q2 		$2.39M Buy
+289,990
New +$2.47M 0.21% 70

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zazove Associates's FLXN Position: Q3 2021 in Review

Zazove Associates increased its Flexion Therapeutics, Inc. (FLXN) stake by 27% in Q3 2021, buying an estimated $489K and bringing the position to 368,456 shares worth $2.25M. The position accounts for 0.2% of the portfolio, ranked #70.

Zazove Associates first reported a position in FLXN in Q2 2021 and has held it in 2 quarters since. The position peaked at $2.39M in Q2 2021. 145 funds tracked by Wall St. Rank hold FLXN as of Q3 2021.

  • Zazove Associates held 368,456 shares of Flexion Therapeutics, Inc. worth $2.25M as of Q3 2021.
  • Zazove Associates bought 78,466 Flexion Therapeutics, Inc. shares in Q3 2021, an estimated $489K.
  • Flexion Therapeutics, Inc. made up 0.2% of Zazove Associates's portfolio in Q3 2021, its #70 holding.
  • Zazove Associates first reported a position in Flexion Therapeutics, Inc. in Q2 2021 and has held it in 2 quarters since.
  • Zazove Associates's Flexion Therapeutics, Inc. position peaked at $2.39M in Q2 2021.
  • 145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2021.

Based on Zazove Associates's 13F filing for Q3 2021, filed 25 Oct 2021.